{"id":55314,"date":"2023-03-29T16:04:34","date_gmt":"2023-03-29T14:04:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/"},"modified":"2023-03-29T16:04:34","modified_gmt":"2023-03-29T14:04:34","slug":"cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/","title":{"rendered":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting"},"content":{"rendered":"
\n

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc<\/a> (NASDAQ: CDIO) today announced that it is sponsoring Becker\u2019s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the Hyatt Regency Hotel in Chicago. As part of Cardio Diagnostics\u2019 sponsorship, the Company is further introducing their recently launched test, PrecisionCHD, at booth #300.\n<\/p>\n

<\/a><\/p>\n

\nBecker\u2019s Hospital Review conferences are among the healthcare industry\u2019s leading events covering hospital leaders’ business, operational and patient-centered concerns. This annual meeting will bring together over 420 elite hospital and health system executives.\n<\/p>\n

\nCardio Diagnostics\u2019 mission is to help clinicians better detect and treat cardiovascular disease, the leading cause of death in the United States. At the core of its cardiovascular solutions is a proprietary Integrated Genetic-Epigenetic Engine\u2122 created by company founders Meesha Dogan, Ph.D., and Robert Philibert, MD, Ph.D. This technology enables the development of a series of tests for precision prevention and early detection and assists in the personalized treatment of major types of cardiovascular diseases and associated co-morbidities including the already launched Epi+Gen CHD and PrecisionCHD tests. The company will also display Actionable Clinical Intelligence\u2122, a platform for healthcare providers connecting the underlying DNA methylation and single nucleotide polymorphism biomarkers measured by this test to coronary heart disease (CHD).\n<\/p>\n

\n“We are thrilled to sponsor Becker’s Hospital Review 13th Annual Meeting and participate in this important event for hospital and health system executives,” said Meesha Dogan, Ph.D., CEO of the Company. “This is a great opportunity to share our insights on how we are partnering with leading healthcare organizations to deploy our precision molecular cardiovascular medicine technologies that can bend the heart disease curve, help lower costs and improve patient care with a focus on our most recent product launched, PrecisionCHD.”\n<\/p>\n

\nAbout Cardio Diagnostics<\/b>\n<\/p>\n

\nCardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (\u201cCore Technology\u201d) for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. For more information, please visit www.cardiodiagnosticsinc.com<\/a>.\n<\/p>\n

\nForward-Looking Statements\n<\/p>\n

\nThis press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “should,” “believe,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, without limitation, the Company\u2019s expectations with respect to future performance, development and commercialization of products and services, the potential benefits and impact of the Company\u2019s products and services, potential regulatory approvals, and the size and potential growth of current or future markets for the Company\u2019s products and services. Forward-looking statements are statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These statements are based on various assumptions, whether or not identified in this press release, and are not intended to serve as, and they must not be relied on by an investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Factors that may cause such differences include, but are not limited to: the success, cost and timing of the Company\u2019s product development and commercialization activities, including the degree that Epi+Gen CHD\u2122 and PrecisionCHD\u2122 tests are accepted and adopted by patients, healthcare professionals and participants in other key channels; the impact of COVID-19 on the Company\u2019s business; economic conditions, dependence on management, dilution to stockholders, lack of capital, changes in laws or regulations, the effects of rapid growth upon the Company and the ability of management to execute our growth strategy and ability to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company\u2019s ability to compete, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. Such factors could materially adversely affect the Company\u2019s financial performance and could cause the Company\u2019s actual results for future periods to differ materially from any opinions or statements expressed within this press release.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:
\n
Gene Mannheimer
\n
Investor Relations
\n
855-226-9991
\n
investors@cardiodiagnosticsinc.com<\/a>\n<\/p>\n

\nMedia & Public Relations:
\n
Khullani Abdullahi
\n
pr@cardiodiagnosticsinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (NASDAQ: CDIO) today announced that it is sponsoring Becker\u2019s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the Hyatt Regency Hotel in Chicago. As part of Cardio Diagnostics\u2019 sponsorship, the Company is further introducing their recently launched test, PrecisionCHD, at booth #300. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55314","6":"format-standard","7":"category-industry"},"yoast_head":"\nCardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (NASDAQ: CDIO) today announced that it is sponsoring Becker\u2019s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the Hyatt Regency Hotel in Chicago. As part of Cardio Diagnostics\u2019 sponsorship, the Company is further introducing their recently launched test, PrecisionCHD, at booth #300. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-29T14:04:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting\",\"datePublished\":\"2023-03-29T14:04:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/\"},\"wordCount\":791,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005657\\\/en\\\/1750618\\\/21\\\/logo_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/\",\"name\":\"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005657\\\/en\\\/1750618\\\/21\\\/logo_%281%29.jpg\",\"datePublished\":\"2023-03-29T14:04:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005657\\\/en\\\/1750618\\\/21\\\/logo_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005657\\\/en\\\/1750618\\\/21\\\/logo_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend","og_description":"CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (NASDAQ: CDIO) today announced that it is sponsoring Becker\u2019s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the Hyatt Regency Hotel in Chicago. As part of Cardio Diagnostics\u2019 sponsorship, the Company is further introducing their recently launched test, PrecisionCHD, at booth #300. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-29T14:04:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting","datePublished":"2023-03-29T14:04:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/"},"wordCount":791,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/","name":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg","datePublished":"2023-03-29T14:04:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230329005657\/en\/1750618\/21\/logo_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-13th-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cardio Diagnostics Holdings, Inc Sponsors Becker\u2019s Hospital Review 13th Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55314"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55314\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}